Rookie Opinion:I think this stock is poised to rip Higher. This is an Under the Radar Pharma company located in Waltham, Massachusetts. It has a PH3 Polyvalent vaccine. Gilead is in thsi company too endpts.com Gilead's virology lead and remdesivir developer Brainard jumps ship to run AlloVir By Ben AdamsMar 23, 2021 07:25a www.fiercebiotech.com "FDA Grants Regenerative Medicine Advanced Therapy (RMAT) Designation to AlloVir’s Posoleucel for Prevention of Multiple Life-Threatening Infections from Six Viruses in Allogeneic Hematopoietic Cell Transplant Patients" ir.allovir.com Link of the pipeline: www.allovir.comby rakataplun0
May see a big selloff, beware! 💰These are just the sales for this year: 2022-03-11 19:14:59 2022-03-10 ALVR Hallal David Dir, 10% S - Sale $7.48 -65,725 17,427,929 0% -$491,850 2022-03-03 16:15:47 2022-03-02 ALVR Van Beek Jeroen B Chief Commercial Officer S - Sale $9.01 -516 382,384 0% -$4,651 2022-02-18 16:30:44 2022-02-16 ALVR Van Beek Jeroen B Chief Commercial Officer S - Sale $8.32 -15,322 382,900 -4% -$127,525 2022-02-10 17:03:24 2022-02-10 ALVR Bornstein Jeffrey S Dir P - Purchase $8.87 +5,000 35,197 +17% +$44,350 2022-01-26 16:15:28 2022-01-25 ALVR Atillasoy Ercem See Remarks S - Sale $8.24 -4,639 100,347 -4% -$38,248 2022-01-25 16:15:11 2022-01-24 ALVR Hallal David Dir, 10% S - Sale $8.01 -17,100 17,493,654 0% -$136,889 2022-01-24 16:15:25 2022-01-20 ALVR Van Beek Jeroen B Chief Commercial Officer S - Sale $8.75 -4,656 398,222 -1% -$40,752 2022-01-24 16:15:20 2022-01-20 ALVR Hagen Brett R Chief Accounting Officer S - Sale $8.75 -1,563 63,202 -2% -$13,680 2022-01-24 16:15:11 2022-01-20 ALVR Sinha Vikas See Remarks S - Sale $8.75 -6,450 14,279,927 0% -$56,454 Shortby unfair_advantage1
$ALVR Allovir Inc $60.00 Breakout target Potential entry level above $49.00 target price $60.00 to Fibonacci Cluster. indicators bullish. Longby RedHotStocks6